SPK Acquisition Corp (SPK) Financial Statements (2024 and earlier)

Company Profile

Business Address ROOM 368, 302 BUWEI
SHANGHAI, 200131
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2022
MRQ
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 50,914
Short-term investments 50,914
Other undisclosed current assets 367
Total current assets: 51,281
Noncurrent Assets
TOTAL ASSETS: 51,281
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 103
Accounts payable 103
Due to related parties 3
Other undisclosed current liabilities 1,548
Total current liabilities: 1,654
Noncurrent Liabilities
Total liabilities: 1,654
Temporary equity, carrying amount 136
Equity
Equity, attributable to parent (1,285)
Common stock 0
Accumulated deficit (1,285)
Other undisclosed equity 50,776
Total equity: 49,491
TOTAL LIABILITIES AND EQUITY: 51,281

Income Statement (P&L) ($ in thousands)

9/30/2022
TTM
12/31/2021
Revenues 1,021
Underwriting income1,018
Gross profit: 1,021
Operating expenses (423)
Operating income: 599
Income from continuing operations: 599
Income before gain (loss) on sale of properties:176
Loss from discontinued operations (423)
Other undisclosed net loss (597)
Net loss attributable to parent: (421)
Other undisclosed net income available to common stockholders, basic 842
Net income available to common stockholders, basic: 421
Other undisclosed net loss available to common stockholders, diluted (842)
Net loss available to common stockholders, diluted: (421)

Comprehensive Income ($ in thousands)

9/30/2022
TTM
12/31/2021
Net loss: (421)
Comprehensive loss, net of tax, attributable to parent: (421)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: